Nov 16 (Reuters) - LAVA Therapeutics NV LVTX.O :
* LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
THIRD
QUARTER FINANCIAL RESULTS
* LAVA THERAPEUTICS NV Q3 EARNINGS PER SHARE $0.04
* LAVA THERAPEUTICS- CASH &INVESTMENTS OF $92.7 MILLION AS
OF
SEPTEMBER 30, PLUS$50.0 MILLION RECEIVED FROM SEAGEN IN OCT
PROVIDE CASH RUNWAY BEYOND 2024
* LAVA THERAPEUTICS NV - QTRLY RESEARCH AND LICENSE REVENUE
$15.3
MILLION
Source text for Eikon: ID:nGNX2GNL0n
Further company coverage: LVTX.O
((Reuters.Briefs@thomsonreuters.com;))